Preventing venous thromboembolism during pregnancy and postpartum: crossing the threshold.

ABSTRACT: When should a patient with a known thrombophilia or prior venous thromboembolism (VTE) receive low-molecular-weight heparin (LMWH) prophylaxis during pregnancy and/or the postpartum period? Accurately predicting thrombotic and bleeding risks and knowing what to do with this information is at the heart of decision-making in these challenging scenarios. This article will explore the concept of a risk threshold from clinician and patient perspectives and provide guidance for the use of antepartum and postpartum LMWH prophylaxis in women with a known thrombophilia or prior VTE. Advice for the management of LMWH prophylaxis use around labor and delivery is also reviewed.

SUBMITTER: Skeith L 

PROVIDER: S-EPMC6142533 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature